Stock Research for ALIM

ALIM

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ALIM Stock Chart & Research Data

The ALIM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ALIM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ALIM Due diligence Resources & Stock Charts

The ALIM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ALIM Detailed Price Forecast - CNN Money CNN View ALIM Detailed Summary - Google Finance
Yahoo View ALIM Detailed Summary - Yahoo! Finance Zacks View ALIM Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ALIM Trends & Analysis - Trade-Ideas Barrons View ALIM Major Holders - Barrons
NASDAQ View ALIM Call Transcripts - NASDAQ Seeking View ALIM Breaking News & Analysis - Seeking Alpha
Spotlight View ALIM Annual Report - CompanySpotlight.com OTC Report View ALIM OTC Short Report - OTCShortReport.com
TradeKing View ALIM Fundamentals - TradeKing Charts View ALIM SEC Filings - Bar Chart
WSJ View Historical Prices for ALIM - The WSJ Morningstar View Performance/Total Return for ALIM - Morningstar
MarketWatch View the Analyst Estimates for ALIM - MarketWatch CNBC View the Earnings History for ALIM - CNBC
StockMarketWatch View the ALIM Earnings - StockMarketWatch MacroAxis View ALIM Buy or Sell Recommendations - MacroAxis
Bullish View the ALIM Bullish Patterns - American Bulls Short Pains View ALIM Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ALIM Stock Mentions - StockTwits PennyStocks View ALIM Stock Mentions - PennyStockTweets
Twitter View ALIM Stock Mentions - Twitter Invest Hub View ALIM Investment Forum News - Investor Hub
Yahoo View ALIM Stock Mentions - Yahoo! Message Board Seeking Alpha View ALIM Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ALIM - SECform4.com Insider Cow View Insider Transactions for ALIM - Insider Cow
CNBC View ALIM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ALIM - OTC Markets
Yahoo View Insider Transactions for ALIM - Yahoo! Finance NASDAQ View Institutional Holdings for ALIM - NASDAQ


Stock Charts

FinViz View ALIM Stock Insight & Charts - FinViz.com StockCharts View ALIM Investment Charts - StockCharts.com
BarChart View ALIM Stock Overview & Charts - BarChart Trading View View ALIM User Generated Charts - Trading View




Latest Financial News for ALIM


Alimera Announces Expansion of Agreement with Distribution Partner Horus Pharma to Include Marketing ILUVIEN® in Benelux Countries
Posted on Thursday September 12, 2019

Alimera Sciences, Inc. (ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces that it has expanded its relationship with Horus Pharma, one of the Company’s current distributors of ILUVIEN® in Europe.


Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management
Posted on Thursday September 05, 2019

Alimera Sciences, Inc. (ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, today announced that its board of directors has approved a proposal to effect a reverse stock split of its common stock. The reverse stock split is expected to result in a higher per share price and a corresponding lower number of total shares issued and outstanding, which should enable Alimera to attain the minimum $1.00 per share bid price requirement for its common stock as required for continued listing on the Nasdaq Global Market. Alimera believes that a reverse stock split can help increase the marketability of its stock to a broader range of potential investors.


Alimera Sciences Launches ILUVIEN® in Germany For Non-Infectious Uveitis Indication
Posted on Tuesday September 03, 2019

Alimera Sciences, Inc. (ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces that it will immediately commence the launch of ILUVIEN in Germany for the prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye (NIPU). Following the European Union’s Mutual Recognition Procedure in March 2019, Germany is the second country in Europe in which ILUVIEN is now commercially available to be prescribed to patients suffering from NIPU, a disease with no sustained treatment options.


How Much Of Alimera Sciences, Inc. (NASDAQ:ALIM) Do Institutions Own?
Posted on Tuesday August 06, 2019

Every investor in Alimera Sciences, Inc. (NASDAQ:ALIM) should be aware of the most powerful shareholder groups...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.